cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Stockal+Disclaimer.pdf
18 own
47 watching
Current Price
$0.86
$0.09
(11.56%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
53.85M
52-Week High
52-Week High
11.90000
52-Week Low
52-Week Low
0.73000
Average Volume
Average Volume
0.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
23.1926
iconMarket Capitalization53.85M
icon52-Week High11.90000
icon52-Week Low0.73000
iconAverage Volume0.04M
iconDividend Yield--
iconP/E Ratio23.1926
What does the Stockal+Disclaimer.pdf do?
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States. It offers Accelerate Pheno system, an vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
PR Newswire
10 months ago
Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform...
PR Newswire
11 months ago
Accelerate Diagnostics scheduled call to review 2023 first quarter results Accelerate Diagnostics scheduled call to review 2023 first quarter results PR Newswire TUCSON, Ariz., April 27, 2023 TUCSON, Ariz., April 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today...
Zolmax
1 year ago
Accelerate Diagnostics, Inc. (NASDAQ:AXDX Get Rating) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 5,070,000 shares, an increase of 7.2% from the February 28th total of 4,730,000 shares. Based on an average daily volume of ...
PR Newswire
1 year ago
Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement PR Newswire TUCSON, Ariz., March 14, 2023 TUCSON, Ariz., March 14...
Zolmax
1 year ago
StockNews.com lowered shares of Accelerate Diagnostics (NASDAQ:AXDX Get Rating) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning. Accelerate Diagnostics Trading Down 3.7 % Shares of NASDAQ AXDX opened at $0.70 on Wednesday. The firm has a market cap of...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$0.86
$0.09
(11.56%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
AVROBIO INC
AVROBIO INC
$1.20
$-0.04 (-3.23 %)
Coherus BioSciences Inc
Coherus BioSciences Inc
$2.07
$0.07 (3.50 %)
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$9.68
$-0.52 (-5.10 %)
bluebird bio, Inc.
bluebird bio, Inc.
$1.02
$0.07 (7.37 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
AVROBIO INC
AVROBIO INC
$1.20
$-0.04 (-3.23 %)
Coherus BioSciences Inc
Coherus BioSciences Inc
$2.07
$0.07 (3.50 %)
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$9.68
$-0.52 (-5.10 %)
bluebird bio, Inc.
bluebird bio, Inc.
$1.02
$0.07 (7.37 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00